REED ELIZABETH E

CIK 00012833033 companiesSAN DIEGO, CA

SEC Profile

Transactions

Companies

Filings

CIK

0001283303

Recent Transactions

50 trades

Exercise/Conversion
Travere Therapeutics, Inc.$TVTX
Common Stock
2026-01-20$19.08/sh+10,000→ 100,270 total
Sale
Travere Therapeutics, Inc.$TVTX
Common Stock
2026-01-20$27.34/sh−10,000→ 90,270 total
Exercise/Conversion
Travere Therapeutics, Inc.$TVTX
Employee stock option (right to buy)
2026-01-20−10,000→ 30,000 total
Exercise/Conversion
Travere Therapeutics, Inc.$TVTX
Employee stock option (right to buy)
2025-09-22−10,000→ 40,000 total
Sale
Travere Therapeutics, Inc.$TVTX
Common Stock
2025-09-22$25.00/sh−10,000→ 89,878 total
Exercise/Conversion
Travere Therapeutics, Inc.$TVTX
Common Stock
2025-09-22$19.08/sh+10,000→ 99,878 total
Sale
Travere Therapeutics, Inc.$TVTX
Common Stock
2025-05-05$21.05/sh−4,920→ 89,482 total
Exercise/Conversion
Travere Therapeutics, Inc.$TVTX
Common Stock
2025-05-02+4,920→ 94,402 total
Exercise/Conversion
Travere Therapeutics, Inc.$TVTX
Performance-based restricted stock units
2025-05-02−4,920→ 4,920 total
Sale
Travere Therapeutics, Inc.$TVTX
Common Stock
2025-02-12$23.53/sh−8,000→ 89,482 total
Exercise/Conversion
Travere Therapeutics, Inc.$TVTX
Performance-based restricted stock units
2025-02-10−8,000→ 0 total
Exercise/Conversion
Travere Therapeutics, Inc.$TVTX
Common Stock
2025-02-10+8,000→ 97,482 total
Sale
Travere Therapeutics, Inc.$TVTX
Common Stock
2025-02-03$19.78/sh−8,951→ 89,482 total
Award
Travere Therapeutics, Inc.$TVTX
Common Stock
2025-01-31+21,500→ 98,433 total
Award
Travere Therapeutics, Inc.$TVTX
Employee stock option (right to buy)
2025-01-31+58,000→ 58,000 total
Sale
Travere Therapeutics, Inc.$TVTX
Common Stock
2025-01-22$19.46/sh−2,437→ 76,933 total
Sale
Travere Therapeutics, Inc.$TVTX
Common Stock
2024-09-09$11.52/sh−4,387→ 78,633 total
Award
Travere Therapeutics, Inc.$TVTX
Common Stock
2024-09-05+6,750→ 83,020 total
Sale
Travere Therapeutics, Inc.$TVTX
Common Stock
2024-02-01$8.86/sh−2,590→ 76,270 total
Sale
Travere Therapeutics, Inc.$TVTX
Common Stock
2024-02-01$8.53/sh−2,174→ 78,860 total
Award
Travere Therapeutics, Inc.$TVTX
Employee stock option (right to buy)
2024-01-31+65,000→ 65,000 total
Award
Travere Therapeutics, Inc.$TVTX
Common Stock
2024-01-31+25,000→ 81,034 total
Sale
Travere Therapeutics, Inc.$TVTX
Common Stock
2024-01-23$8.96/sh−2,062→ 56,034 total
Sale
Travere Therapeutics, Inc.$TVTX
Common Stock
2023-09-05$14.71/sh−1,815→ 58,096 total
Award
Travere Therapeutics, Inc.$TVTX
Common Stock
2023-08-31+3,300→ 59,911 total
Sale
Travere Therapeutics, Inc.$TVTX
Common Stock
2023-05-10$16.59/sh−825→ 56,611 total
Sale
Travere Therapeutics, Inc.$TVTX
Common Stock
2023-02-01$22.25/sh−2,590→ 57,436 total
Award
Travere Therapeutics, Inc.$TVTX
Employee stock option (right to buy)
2023-01-31+54,500→ 54,500 total
Award
Travere Therapeutics, Inc.$TVTX
Common Stock
2023-01-31+20,250→ 60,026 total
Award
Travere Therapeutics, Inc.$TVTX
Performance-based restricted stock units
2023-01-31+6,750→ 6,750 total
Sale
Travere Therapeutics, Inc.$TVTX
Common Stock
2023-01-24$21.50/sh−2,062→ 39,776 total
Sale
Travere Therapeutics, Inc.$TVTX
Common Stock
2022-05-12$21.51/sh−1,050→ 41,838 total
Sale
Travere Therapeutics, Inc.$TVTX
Common Stock
2022-05-10$21.51/sh−900→ 42,888 total
Award
Travere Therapeutics, Inc.$TVTX
Common Stock
2022-01-31+9,840→ 45,138 total
Award
Travere Therapeutics, Inc.$TVTX
Performance-based restricted stock units
2022-01-31+8,000→ 8,000 total
Award
Travere Therapeutics, Inc.$TVTX
Performance-based restricted stock units
2022-01-31+9,840→ 9,840 total
Award
Travere Therapeutics, Inc.$TVTX
Employee stock option (right to buy)
2022-01-31+39,360→ 39,360 total
Sale
Travere Therapeutics, Inc.$TVTX
Common Stock
2022-01-31$27.40/sh−1,350→ 43,788 total
Sale
Travere Therapeutics, Inc.$TVTX
Common Stock
2022-01-24$24.98/sh−2,250→ 35,298 total
Sale
Travere Therapeutics, Inc.$TVTX
Common Stock
2022-01-11$27.40/sh−5,000→ 37,548 total
Award
Travere Therapeutics, Inc.$TVTX
Common Stock
2022-01-10+5,000→ 42,548 total
Sale
Travere Therapeutics, Inc.$TVTX
Common Stock
2021-08-17$17.12/sh−1,407→ 37,548 total
Award
Travere Therapeutics, Inc.$TVTX
Common Stock
2021-08-13+4,500→ 38,955 total
Sale
Travere Therapeutics, Inc.$TVTX
Common Stock
2021-05-12$19.46/sh−1,625→ 34,455 total
Sale
Travere Therapeutics, Inc.$TVTX
Common Stock
2021-05-11$19.14/sh−1,625→ 36,080 total
Sale
Travere Therapeutics, Inc.$TVTX
Common Stock
2021-02-08$31.58/sh−2,250→ 37,705 total
Sale
Travere Therapeutics, Inc.$TVTX
Common Stock
2021-02-05$31.41/sh−2,250→ 39,955 total
Award
Travere Therapeutics, Inc.$TVTX
Common Stock
2021-02-03+4,500→ 42,205 total
Sale
Travere Therapeutics, Inc.$TVTX
Common Stock
2021-02-03$28.91/sh−675→ 37,705 total
Sale
Travere Therapeutics, Inc.$TVTX
Common Stock
2021-02-03$28.91/sh−2,500→ 38,380 total

Companies

Recent Filings

Address

C/O TRAVERE THERAPEUTICS, INC. 3611 VALLEY CENTRE DR., SUITE 300

SAN DIEGO, CA, 92130

View on SEC.gov